Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease.

Abstract excerpt

Fatty liver disease (FLD), including its more severe pathologies, namely steatohepatitis, hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease worldwide and is projected to become the leading cause of hepatocellular carcinoma and end-stage liver disease. FLD is heterogeneous with multiple etiologies and diverse histological phenotypes, so therapies will ultimately need to be...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Discovery
• Share to Genetics, Medical
• Share to Lipid Metabolism